Invivoscribe Licenses Patent from Takara for FLT3-ITD Mutation Detection | GenomeWeb

NEW YORK (GenomeWeb News) – Invivoscribe Technologies today said it has licensed a patent from Takara Bio for detecting internal tandem duplication mutations in the FLT3 gene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.